What's breaking now, across thousands of outlets.
The shots have been approved for people 65 and older, and for younger people with underlying conditions. Others may be able to get them off label.
We haven't written up this one. The New York Times has the full story — the link below goes straight to it.
(MedPage Today) -- The FDA approved the first oral treatment option for the autoimmune disorder dermatomyositis. Brepocitinib (Lisraya) is indicated for adults with the rare condition, which causes…
Precancerous blood cells can actively reshape their surroundings, prematurely aging cells in the bone marrow to create conditions that favor their own growth and potentially increase the risk of blood…
(MedPage Today) -- Hormone replacement therapy (HRT) was tied to a lower risk of dementia in a prospective study of nearly 185,000 postmenopausal women in the U.K. Biobank.
(MedPage Today) -- In the wake of two measles-associated deaths in Pennsylvania, including an infant, Health Secretary Robert F. Kennedy Jr.
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
